About the Partnership for Safe Medicines India
The Partnership for Safe Medicines India is a group of organizations and individuals that have policies, procedures, or programs to protect consumers from spurious or contraband medicines. For more information, please visit www.safemedicinesindia.in
PSM LOGO 1st June
News Archive
Editor's Emulsion

Pooja Khaitan


With the summer holidays in full swing and the heat increasing by the day , children are inclined to be falling ill. It is as parents that we need to treat them best , with love and the right medication. If your child is prescribed antibiotics be sure to:
Use antibiotics as prescribed.
Don't save antibiotics for next time.
Never use another person's prescription.

Ask your doctor about ways to treat the symptoms that are making your child uncomfortable, such as a stuffy nose or scratchy throat, without the use of antibiotics. The key to building a good relationship with your doctor is open communication, so work together towards that goal.
Use the medication properly. Antibiotics are only effective against a bacterial infection if taken for the full amount of time prescribed by the doctor — and they take time to kick in, too, so don't expect your child to feel better after taking the first dose. Most kids take 1 to 2 days to feel a lot better. Similarly, don't let your child take antibiotics longer than prescribed. And most important, never use antibiotics that have been lying around your home.
Enjoy your holidays and BE SAFE !!

Pooja Khaitan
(We welcome your valuable suggestions and news articles. Please feel free to write to me at pooja@safemedicinesindia.in )
To register a complaint kindly visit our consumer redressal website www.consumerconexion.org . We shall be delighted to help you.

Dose of the day
Upcoming Events

31 August-5 Sep. DUBLIN 2013 FIP World Congress

24th Oct. 2013 Washington, D.C PSM Interchange 2013

National Injections
FDA cracks down on addictive cough syrups
MUMBAI, May, 2013: To curb over-the-counter sale of addictive cough syrups, the food and drug administration (FDA) has asked Narcotics Control Board (NCB) to regulate supply of codeine phosphate.
Read More
Guj FDCA busts racket in Ahmedabad selling spurious drugs of top brands
MUMBAI, May, 2013: The Gujarat Food and Drug Control Administration (FDCA) recently busted a racket of illegal manufacturing and sale of spurious drugs in Ahmedabad. In a raid carried out by the the FDCA officials, the authorities seized drugs worth Rs.2 lakhs from the main accused Jayesh Mehta's residence, which he had stocked without any valid license.
Read More
Fake cosmetics, medicines flood Patna market
PATNA, May, 2013: The state capital has become a favourite market for fake cosmetics and spurious medicines. The recovery of consignments and unearthing the manufacturing units of counterfeit products recently have also proved that the 'business' has been running across the state with Patna being the easy route.
Read More
Drug Law and Policy Injections
FDA makes WHO-GMP certificate filing online

MUMBAI, May, 2013: The Food and Drug Administration has launched a software for filing an application, processing and issuing of WHO-GMP certificates mandatory for export of medicines.

Read More
CCI directs AIOCD from obtaining NOC for appointing stockists, PIS charges from pharma companies

CHENNAI, May, 2013: Following the direction of the Competition Commission of India (CCI), the All India Organisation of Chemists & Druggists (AIOCD) has issued a circular to its members and office-bearers of state associations communicating the orders of the Commission.

Read More
Sale of pentavalent vaccine stopped

CHENNAI, May, 2013: The drug controller-general of India (DCG) has clarified that no permission has been given to Delhi-based Panacea Biotec to sell re-labelled vials of a pentavalent vaccine manufactured by the company across the country.

Read More
Global Injections
US FDA: Sandoz recall methotrexate

WASHINGTON, May, 2013: The U.S. Food and Drug Administration (FDA) announced this morning that Sandoz is conducting a voluntary recall of its Methotrexate Sodium USP, 25 mg/mL, 40 mL injectable products. The manufacturer discovered particulate matter in vials during a routine quality inspection of retention samples.

Read More
FDA Drug Safety Communication

The U.S. Food and Drug Administration (FDA) is notifying the public that FDA has approved label changes specifying new dosing recommendations for zolpidem products (Ambien, Ambien CR, and Edluar), which are widely prescribed sleep medications. FDA has approved these changes because of the known risk of next-morning impairment with these drugs.

Read More
Pharma Injections
Products declared Not of Standard Quality

Aurangabad View Details

Mumbai View Details

This Newsletter brought to you by

Jan Aushadhi Logo


Follow US on Faceboook

Follow US on twitter

© 2011 Partnership for Safe Medicines India E-15/A, first floor, East of Kailash, New Delhi -110065
www.safemedicinesindia.in; www.safemedicines.org; www.ConsumerConexion.org
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .PSM India may not be held responsible for any article published in PSM NEWZ .